The global antifreeze proteins market is expected to grow significantly over the forecast period from 2023 to 2028. The market is estimated to be worth USD 10 million in 2023 and is projected to reach USD 50 million by 2028, with a compound annual growth rate (CAGR) of 37.2%.
Antifreeze Proteins Market: Type III Collagen and Liquid Form Segment to Witness Significant Growth
The antifreeze proteins market is poised for substantial growth, with Type III collagen and the liquid form segment projected to be major contributors. Type III marine collagen, primarily extracted from fish, stands as the second most vital and viable source of antifreeze proteins. Its effective combination with Type I collagen makes it highly sought after in the medical and cosmetic industries, driving substantial demand for Type III antifreeze proteins across diverse applications.
Liquid Form Antifreeze Proteins to Hold Prominent Market Share
The liquid form of antifreeze proteins is anticipated to occupy the second-largest market share during the forecast period, owing to its increasing application in cryopreservation. Despite having fewer applications compared to the solid form, the liquid form finds extensive usage in cosmetics and cryopreservation within the pharmaceutical sector.
Medical Segment: Largest Market Share in Antifreeze Proteins Market
The medical segment is expected to dominate the market, driving significant demand for antifreeze proteins due to their anti-infectant properties against viruses, bacteria, and fungi. Regulatory approval from food safety authorities for the use of antifreeze proteins in pharmaceutical products has further fueled their demand, considering the multiple health benefits they offer. Moreover, their high absorption rate in the human body provides enhanced healing and repair opportunities.
Insects Segment: Highest CAGR Anticipated
The insects segment is projected to witness the highest compound annual growth rate (CAGR) during the study period. Insect antifreeze proteins, sourced from various types of insects like crickets, black soldier flies, mealworms, ants, and grasshoppers, are known for their high-quality protein content. Additionally, insects like grasshoppers and beetles are being explored for medicinal applications to treat both zoonotic and human diseases, although their pharmaceutical use is still at a preliminary stage.
In conclusion, the antifreeze proteins market is set to witness significant growth, with Type III collagen and the liquid form segment playing pivotal roles. The medical segment is expected to lead the market due to the extensive demand for antifreeze proteins' anti-infectant properties and health benefits. Furthermore, the insects segment is poised for rapid expansion, presenting diverse opportunities for innovation and applications in the coming years.
Key players in the antifreeze proteins market include Nichirei Corporation (Japan), Kaneka Corporation (Japan), A/F Protein Inc. (US), Sirona Biochem (Canada), Unilever (Netherlands), ProtoKinetix, Inc. (US), Shanghai Yu Tao Industrial Co., Ltd. (China), Kodera Herb Garden Co., Ltd (Japan), Beijing Huacheng Jinke Technology Co., Ltd. (China), Rishon Biochem Co., Ltd (China), and MyBiosource, Inc. (US).
Sign in to leave a comment.